These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2113352)

  • 1. Hemostatic variables in Japanese and Caucasian men. Tissue plasminogen activator, antithrombin III, and protein C and their relations to coronary risk factors.
    Iso H; Folsom AR; Wu KK; Finch A; Sato S; Munger RG; Shimamoto T; Terao A; Komachi Y
    Am J Epidemiol; 1990 Jul; 132(1):41-6. PubMed ID: 2113352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors.
    Iso H; Folsom AR; Wu KK; Finch A; Munger RG; Sato S; Shimamoto T; Terao A; Komachi Y
    Am J Epidemiol; 1989 Nov; 130(5):925-34. PubMed ID: 2510500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women.
    Iso H; Folsom AR; Koike KA; Sato S; Wu KK; Shimamoto T; Iida M; Komachi Y
    Thromb Haemost; 1993 Sep; 70(3):475-80. PubMed ID: 8259552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
    Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
    Barton MH; Morris DD; Norton N; Prasse KW
    J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passage of the menopause is followed by haemostatic changes.
    Lindoff C; Petersson F; Lecander I; Martinsson G; Astedt B
    Maturitas; 1993 Jul; 17(1):17-22. PubMed ID: 8412839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease.
    He WJ; Hu Y; Zhang XP; Hong M; Guo T; Wei WN; Song SJ
    Eur J Med Res; 2008 Feb; 13(2):47-51. PubMed ID: 18424361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic risk factors of coronary artery disease in the Chinese.
    Ho CH; Wang SP; Jap TS
    Int J Cardiol; 1995 Aug; 51(1):79-84. PubMed ID: 8522401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue plasminogen activator, its inhibitor and other factors of the blood fibrinolytic system in stable coronary heart disease].
    Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN
    Kardiologiia; 1992 Feb; 32(2):9-12. PubMed ID: 1527946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
    Lindoff C; Peterson F; Lecander I; Martinsson G; Astedt B
    Maturitas; 1996 May; 24(1-2):43-50. PubMed ID: 8794433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinogen, tissue plasminogen activator, plasminogen activator inhibitor 1, and their related factors in three Japanese population samples.
    Koike KA; Iso H; Shimamoto T; Kudo M; Umemura U; Sato S; Naito Y; Iida M; Komachi Y
    Environ Health Prev Med; 1998 Oct; 3(3):158-63. PubMed ID: 21432496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.